80.15CHF-0.06%Mkt Cap: 3.51B CHFP/E: 20.87Last update: 2026-05-13
Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including …
Industry Peers
Drug Manufacturers - Specialty & Genericloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)20.87
P/E (Forward)17.36
PEG2.56
P/B3.06
P/S2.60
EV/EBITDA12.74
EV/Revenue2.96
EPS (TTM)3.84
EPS (Forward)4.55
Cash Flow & Leverage
FCF Yield-0.59%
FCF Margin-1.57%
Operating CF228.16M CHF
CapEx (TTM)231.47M CHF
Net Debt/EBITDA1.53
Net Debt471.40M CHF
Technical
SMA 5078.35 (+2.3%)
SMA 20080.91 (-0.9%)
Beta0.77
S&P 52W Chg24.23%
Avg Vol (30d)78.90K
Avg Vol (10d)74.29K
Technical Indicators
RSI (14)50.3
MACD0.5710
MACD Signal0.5021
MACD Hist.+0.0689
BB Upper84.82 CHF
BB Middle80.67 CHF
BB Lower76.51 CHF
BB Width10.30%
ATR (14)2.321 CHF
Vol Ratio (20d)0.54x
52W Range
68.5035% of range101.60
52W High101.60 CHF
52W Low68.50 CHF
Profitability
Gross Margin26.66%
EBITDA Margin23.21%
Profit Margin12.70%
Oper. Margin18.83%
ROE14.95%
ROA7.83%
Revenue Growth5.00%
Earnings Growth16.00%
Balance Sheet
Debt/Equity51.01
Current Ratio2.00
Quick Ratio1.14
Book Value/Sh25.75 CHF
Cash/Share2.369 CHF
Dividends
Fwd Div Rate0.4000 CHF
Trail. Div Rate0.4000 CHF
Div. Yield0.51%
5Y Avg Yield0.72%
Payout Ratio9.90%
Ex-Div DateApr 28, 2026
Pay DateApr 24, 2025
Splits
Last Split10:1
Split DateApr 28, 2025
Ownership
Shares Out.43.81M
Float39.80M
Insiders13.23%
Institutions54.57%
Analyst Consensus
Rating1.8 (Buy)
Target (Mean)103.91 CHF
Target Range85.00 CHF – 126.00 CHF
# Analysts11
Company
Market Cap3.51B CHF
Enterprise Value3.93B CHF
Revenue (TTM)1.33B CHF
Gross Profit353.99M CHF
Net Income (TTM)168.66M CHF
Revenue/Share30.34 CHF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees3.9K
Last Price80.15 CHF
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—